JAK Inhibitors in Atopic Dermatitis: Does Weight Matter? A Real-World, Nationwide Retrospective Study: IL-AD (Italian Landscape Atopic Dermatitis)

Abstract Introduction Janus kinase (JAK) inhibitors are effective systemic treatments for moderate-to-severe atopic dermatitis (AD), rapidly controlling symptoms and improving quality of life. However, the impact of body mass index (BMI) on therapeutic response remains unclear. Methods This multicen...

Full description

Bibliographic Details

Published in:	Dermatology and Therapy
Main Authors:	Mariateresa Rossi, Stefano Bighetti, Alessandra Narcisi, Antonio Costanzo, Matteo Bianco, Piergiorgio Malagoli, Francesco Messina, Francesca Gaiani, Silvia Mariel Ferrucci, Angelo Valerio Marzano, Francesca Barei, Simone Ribero, Michela Ortoncelli, Francesco Leo, Maddalena Napolitano, Andrea Cosenza, Cataldo Patruno, Mario Bruno Guanti, Anna Balato, Francesco Loconsole, Claudio Sciarrone, Federica Veronese, Elena Pezzolo, Anna Graziella Burroni, Massimo Gola, Carlotta Gurioli, Flavia Manzo Margiotta, Maria Letizia Musumeci, Francesca Satolli, Giuseppe Amoruso, Maria Esposito, Caterina Foti, Paolo Pella, Anna Campanati, Andrea Carugno, Nicola Zerbinati, Martina Maurelli, Ilaria Trave, PierGiacomo Calzavara-Pinton, Luca Bettolini
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2025-07-01
Subjects:	Atopic dermatitis JAK inhibitors Body mass index Obesity Real-world study Upadacitinib
Online Access:	https://doi.org/10.1007/s13555-025-01477-0